Allergan's besieged Restasis patents get smacked again, this time in retailer antitrust suit
admin 17th May 2018 Uncategorised 0Allergan has already faced heaps of scrutiny for its strategies to protect blockbuster eye drug Restasis from generic competition, but it’ll have to defend itself against a new group of plaintiffs now that four retail pharmacies have launched a lawsuit.
More: Allergan's besieged Restasis patents get smacked again, this time in retailer antitrust suit
Source: fierce